MétaCan
Menu
Back to cohort
Record W2346425602 · doi:10.18632/oncotarget.9168

Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways

2016· article· en· W2346425602 on OpenAlexafffundabout
Shu‐Xiang Cui, Wenna Shi, Zhiyu Song, Shuqing Wang, Xinfeng Yu, Zu‐Hua Gao, Xian‐Jun Qu

Bibliographic record

VenueOncotarget · 2016
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicPI3K/AKT/mTOR signaling in cancer
Canadian institutionsMcGill University
FundersMcGill University Health CentreUniversity of TokyoNational Natural Science Foundation of ChinaMcGill University
KeywordsSorafenibPI3K/AKT/mTOR pathwayMAPK/ERK pathwayProtein kinase BCancer researchHepatocellular carcinomaMedicineSignal transductionApoptosisCell growthTargeted therapyCancerInternal medicineChemistryBiologyCell biologyBiochemistry

Abstract

fetched live from OpenAlex

// Shu-Xiang Cui 1 , Wen-Na Shi 2 , Zhi-Yu Song 2 , Shu-Qing Wang 2 , Xin-Feng Yu 2 , Zu-Hua Gao 3 , Xian-Jun Qu 2 1 Beijing Key Laboratory of Environmental Toxicology, Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, China 2 Department of Pharmacology, Capital Medical University School of Basic Medical Sciences, Beijing, China 3 Department of Pathology, McGill University, Montreal, Quebec, Canada Correspondence to: Xian-Jun Qu, e-mail: quxj@ccmu.edu.cn Zu-Hua Gao, e-mail: zu-hua.gao@mcgill.ca Keywords: human hepatocellular carcinoma (HCC), Sorafenib, des-gamma-carboxy prothrombin (DCP), Ras/Raf/MEK/ERK cascade, Ras/PI3K/Akt/mTOR cascade Received: November 13, 2015     Accepted: April 23, 2016     Published: May 4, 2016 ABSTRACT Despite significant progress, advanced hepatocellular carcinoma (HCC) remains an incurable disease, and the overall efficacy of targeted therapy by Sorafenib remains moderate. We hypothesized that DCP (des-gamma-carboxy prothrombin), a prothrombin precursor produced in HCC, might be one of the reasons linked to the low efficacy of Sorafenib. We evaluated the efficacy of Sorafenib in HLE and SK-Hep cells, both of which are known DCP-negative HCC cell lines. In the absence of DCP, Sorafenib effectively inhibited the growth of HCC and induced cancer cell apoptosis. In the presence of DCP, HCC was resistant to Sorafenib-induced inhibition and apoptosis, as determined by in vitro assays and in mice xenografted with HLE cells. Molecular analysis of HLE xenografted-nude mice showed that DCP activates the transduction of the Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR cascades. DCP might stimulate the formation of compensatory feedback loops in the intricately connected signaling pathways when kinases are targeted by Sorafenib. Our results indicate that DCP antagonizes the inhibitory effects of Sorafenib on HCC through activation of the Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR signaling pathways. Taken together, our findings define a DCP-mediated mechanism of inhibition of Sorafenib in HCC, which is critical for targeting therapy in advanced HCC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score0.635

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.251
Teacher spread0.230 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations26
Published2016
Admission routes3
Has abstractyes

Explore more

Same venueOncotargetSame topicPI3K/AKT/mTOR signaling in cancerFrench-language works237,207